Recent studies have revealed that blocking of TNF-α activity results in the reduction of inflammation in the colon in both experimental colitis model and patients with ulcerative colitis (Lv et al., 2014; Rashidian et al., 2019). This evidence concerns the gene TNF and ulcerative colitis.